Markets:

Overview

News

Currencies

International

Treasuries

Biodesix, Inc. - Common Stock (NQ:BDSX)

7.950 +0.080 (+1.02%)

Streaming Delayed Price Updated: 11:13 AM EST, Nov 28, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Biodesix, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

September 29, 2022

Good morning! We're taking a look at the biggest pre-market stock movers traders need to know about on Thursday morning!

Via InvestorPlace

Why Immunocore Shares Dipped 22%; Here Are 73 Biggest Movers From Friday ↗

September 12, 2022

Gainers Digital Media Solutions, Inc. (NYSE: DMS) shares climbed 71.9% to close at $2.20 on Friday after the company received a non-binding go-private proposal from Prism Data for $2.50 per share in...

Via Benzinga

Biodesix: Q2 Earnings Insights ↗

August 04, 2022

Biodesix (NASDAQ:BDSX) reported its Q2 earnings results on Thursday, August 4, 2022 at 06:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Recap: Biodesix Q1 Earnings ↗

May 11, 2022

Biodesix (NASDAQ:BDSX) reported its Q1 earnings results on Wednesday, May 11, 2022 at 06:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Why Zscaler Is Trading Higher By Around 19%, Here Are 44 Stocks Moving In Friday's Mid-Day Session ↗

September 09, 2022

Gainers Digital Media Solutions, Inc. (NYSE: DMS) shares jumped 70% to $2.1750 after the company received a non-binding go-private proposal from Prism Data for $2.50 per share in cash.

Via Benzinga

Biodesix to Participate in Two Upcoming Investor Conferences in September

September 06, 2022

From Biodesix, Inc.

Via Business Wire

Looking Into Biodesix's Return On Capital Employed ↗

August 22, 2022

Benzinga Pro data, Biodesix (NASDAQ:BDSX) reported Q2 sales of $10.95 million. Earnings fell to a loss of $15.82 million, resulting in a 1.53% decrease from last quarter.

Via Benzinga

Biodesix Named a Top 100 Healthcare Technology Company of 2022

August 09, 2022

From Biodesix, Inc.

Via Business Wire

Biodesix Announces Second Quarter 2022 Results and Highlights

August 04, 2022

From Biodesix, Inc.

Via Business Wire

Biodesix to Present at the Canaccord Genuity 42nd Annual Growth Conference

August 03, 2022

From Biodesix, Inc.

Via Business Wire

12 Health Care Stocks Moving In Friday's After-Market Session ↗

July 29, 2022

Gainers Nanobiotix (NASDAQ:NBTX) shares rose 16.4% to $2.7 during Friday's after-market session. The company's market cap stands at $94.1 million.

Via Benzinga

Biodesix to Present Data at IASLC 2022 World Conference Demonstrating that the VeriStrat® Test is Predictive of Progression Free Survival and Overall Survival in Patients with Low or Negative PD-L1 Treated with Immune Checkpoint Inhibitors

July 20, 2022

From Biodesix, Inc.

Via Business Wire

Biodesix to Report Second Quarter 2022 Financial Results on August 4, 2022

July 19, 2022

From Biodesix, Inc.

Via Business Wire

Akerna Shares Dip 53%, Here's 78 Biggest Movers From Yesterday ↗

July 01, 2022

Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) surged 77.4% to close at $1.11 on Thursday after jumping 27% on Wednesday. Revelation Biosciences recently announced completion of dosing for Phase...

Via Benzinga

Looking Into Biodesix's Return On Capital Employed ↗

June 15, 2022

Benzinga Pro data, Biodesix (NASDAQ:BDSX) reported Q1 sales of $6.55 million. Earnings fell to a loss of $15.59 million, resulting in a 17.35% decrease from last quarter.

Via Benzinga

Biodesix Obtains Medicare Coverage for the Nodify CDT® Lung Nodule Test

June 07, 2022

From Biodesix, Inc.

Via Business Wire

12 Health Care Stocks Moving In Monday's After-Market Session ↗

June 06, 2022

Gainers Vaxxinity (NASDAQ:VAXX) stock moved upwards by 10.2% to $3.56 during Monday's after-market session. The company's market cap stands at $448.5 million.

Via Benzinga

Biodesix Announces Research Agreement with Top US Cancer Center

June 03, 2022

From Biodesix, Inc.

Via Business Wire

Biodesix to Present at the 42nd Annual William Blair Growth Stock Conference

June 01, 2022

From Biodesix, Inc.

Via Business Wire

Biodesix to Present at the H.C. Wainwright Global Investment Conference

May 17, 2022

From Biodesix, Inc.

Via Business Wire

Biodesix Announces New Clinical Utility Evidence for the Nodify XL2® Nodule Risk Assessment Test to be Presented at ATS 2022 International Conference

May 12, 2022

From Biodesix, Inc.

Via Business Wire

Biodesix Announces First Quarter 2022 Results and Highlights

May 11, 2022

From Biodesix, Inc.

Via Business Wire

66 Biggest Movers From Yesterday ↗

May 03, 2022

Gainers Better Therapeutics, Inc. (NASDAQ: BTTX) shares surged 120.4% to close at $2.01 on Monday following a 5% drop on Friday. SoundHound AI, Inc. (NASDAQ: SOUN) shares surged...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

May 02, 2022

Via Benzinga

Biodesix to Report First Quarter 2022 Financial Results on May 11, 2022

April 27, 2022

From Biodesix, Inc.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For April 20, 2022 ↗

April 20, 2022

Upgrades

Via Benzinga

68 Biggest Movers From Yesterday ↗

April 19, 2022

Gainers Casa Systems, Inc. (NASDAQ: CASA) shares surged 82.5% to close at $7.10 on Monday after the company announced a multi-year contract with Verizon to provide 5G core...

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

April 18, 2022

Gainers Rockwell Medical (NASDAQ:RMTI) stock rose 9.2% to $0.4 during Monday's after-market session. The company's market cap stands at $37.5 million.

Via Benzinga

The Daily Biotech Pulse: Aeglea Stock Jumps On Inherited Metabolic Disease Data, Partial Hold Lifted On Gilead's 2 Blood Trials, Early Data From Novartis' KRAS Inhibitor And More ↗

April 12, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

A Peek Into The Markets: US Stock Futures Down Ahead Of March Inflation Report ↗

April 12, 2022

Pre-open movers U.S. stock futures traded lower in early premarket trade after the Nasdaq Composite index closed at 13,411.96, a dip of almost 300 points. Investors are awaiting the annual inflation...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.